Claritev's (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks
On August 7, Claritev Corporation (NYSE:CTEV) reported second-quarter results that beat its own targets, marking five consecutive quarters of year-over-year revenue growth.
Claritev Corp (CTEV)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Beach Point Capital Management Carl Goldsmith And Scott Klein | 750,599 | $15,890,181 | -3% | 6.95% |
| 2. | Renaissance Technologies Jim Simons | 54,332 | $1,150,208 | +19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.14 | 65,579 | $1,714,523.61 | 2,049,518 | 2026-11-10 | Filing | |
| $24.42 | 50,000 | $1,221,105.00 | 1,983,939 | 2026-11-09 | Filing | |
| $26.14 | 65,579 | $1,714,523.61 | 2,049,518 | 2026-11-10 | Filing | |
| $24.42 | 50,000 | $1,221,105.00 | 1,983,939 | 2026-11-09 | Filing | |
| $24.07 | 20,834 | $501,466.05 | 1,933,939 | 2026-10-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.07 | 20,067 | $543,285.93 | 195,490 | 2026-11-12 | Filing | |
| $28.60 | 40,000 | $1,143,844.00 | 215,557 | 2026-11-11 | Filing | |
| $23.75 | 5,500 | $130,625.00 | 255,557 | 2026-11-10 | Filing | |
| $23.81 | 5,812 | $138,390.11 | 107,917 | 2026-10-15 | Filing | |
| $31.19 | 1,148 | $35,810.02 | 185,416 | 2026-09-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,887,858 | $82,305,954 | 100% | |
| 2. | 353,800 | $7,656,233 | 0% | |
| 3. | 241,930 | $5,122,750 | 0% | |
| 4. | 173,648 | $3,676,128 | 0% | |
| 5. | 50,827 | $1,076,008 | 0% |
News See All
Claritev Corporation (NYSE:CTEV) Q1 2026 Earnings Call Transcript
Claritev Corporation (NYSE:CTEV) Q1 2026 Earnings Call Transcript May 7, 2026Claritev Corporation misses on earnings expectations. Reported EPS is $-4.41 EPS, expectations were $-3.81.
Concerns Surrounding AI Pressured Claritev Corp (CTEV)
Third Point Management, a New York-based investment advisor, released its first-quarter 2025 investor letter. Third Point's flagship Offshore Fund returned -0.6% in Q1 2026.
Claritev Corporation (NYSE:CTEV) Q3 2025 Earnings Call Transcript
Claritev Corporation (NYSE:CTEV) Q3 2025 Earnings Call Transcript November 7, 2025Claritev Corporation misses on earnings expectations. Reported EPS is $-4.07 EPS, expectations were $-3.12.
Claritev Corp (CTEV) Bounces to Revenue Growth as Net Loss Shrinks
Claritev Corporation (NYSE:CTEV) is one of the must-buy small-cap stocks to invest in.
10 Must-Buy Small-Cap Stocks to Invest In
In this article, we will take a look at the 10 Must-Buy Small-Cap Stocks to Invest In. Large-cap tech giants have been the catalyst behind the US equity market rallying to record highs.
Claritev Corporation Joins Coalition for Health AI to Advance Responsible AI in Healthcare
Claritev Corporation (NYSE:CTEV) is one of the best-performing NYSE stocks to buy now. On June 17, Claritev Corporation announced its membership in the Coalition for Health AI/CHAI.
10 Best Performing NYSE Stocks to Buy Now
Barbara Doran, CIO at BD8 Capital Partners, joined CNBC on June 20 to discuss how she sees markets holding steady after a strong rebound.
Claritev Upgraded to Overweight at Piper Sandler with a $44 Price Target
Piper Sandler has upgraded Claritev Corporation (NYSE:CTEV) shares, impressed by the company's first quarter 2025 results. On May 28, the firm upgraded the stock to an Overweight from a Neutral.
Hedge Fund Resource Center